Glucagon stimulation test to assess growth hormone status in Prader–Willi syndrome

PURPOSE: Growth hormone deficiency (GHD) must be confirmed before starting treatment in adults with Prader-Willi syndrome (PWS). Most studies use the growth-hormone-releasing hormone plus arginine (GHRH-arginine) test. No data are available on the glucagon stimulation test (GST) in PWS. We compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Casamitjana, L., Giménez-Palop, O., Corripio, R., Pareja, R., Berlanga, E., Rigla, M., Oliva, JC., Caixàs, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878226/
https://www.ncbi.nlm.nih.gov/pubmed/32720093
http://dx.doi.org/10.1007/s40618-020-01367-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878226/
https://www.ncbi.nlm.nih.gov/pubmed/32720093
http://dx.doi.org/10.1007/s40618-020-01367-6

Ejemplares similares